DE SCR78

Proclaims May 2025 as "Cystic Fibrosis Awareness Month" in Delaware

Recognizes cystic fibrosis affects approximately 40,000 children and adults in the United States and over 70,000 worldwide, with more than 75% of patients diagnosed by age two

Highlights medical advancements including FDA approval of Trikafta in 2019, the first triple combination therapy for the most common cystic fibrosis mutations

Notes that life expectancy for people with CF born between 2019-2023 is predicted to be 61 years, compared to the 1950s when few children survived to elementary school

Directs that a copy of the resolution be presented to the Cystic Fibrosis Foundation